📣Sharing the latest research from the Miguel Ramalho-Santos Lab, just released on bioRxiv! We found LINE1 RNA promotes nuclear compartmentalization to repress the 8-cell state in human embryonic stem cells. biorxiv.org/content/10.110… 👇Key findings:

🚨 BIG NEWS! 🚨 We are thrilled to welcome biomodal as a sponsor for the 2025 Cancer Genetics & Epigenetics Gordon Research Conferences ! Their cutting-edge 6-base DNA sequencing technology is a game-changer in the field. 🌐 Learn more at biomodal.com Changing the game—together!

We are recruiting a colleague in the Donnelly Centre at the University of Toronto. We are looking for an assistant professor in the broad area of functional genomics: jobs.utoronto.ca/job/Toronto-As… closing date is Jan 16, 2025 Donnelly Centre University of Toronto Temerty Medicine

📖 New review in Nature Reviews Cancer on how epigenomic heterogeneity drives tumour evolution! We dive into: Check it out if you're into epigenetics, single-cell tech, or the future of cancer therapy! 📖 nature.com/articles/s4156…

📝Epigenomic heterogeneity as a source of tumour evolution Just out in Nature Reviews Cancer - a piece we wrote with Mathieu Lupien and Marthe LAISNE, a fantastic team work and such a pleasure to exchange & confront ideas on cancer epigenetics. 👉nature.com/articles/s4156…

#singlecell epigenomic technologies are redefining our understanding of cancer evolution. Now, Marthe LAISNE, Mathieu Lupien & Céline Vallot explain how epigenomic heterogeneity drives tumor cell state diversity through reprogramming and selection. go.nature.com/3NyflWN

Epigenome Technologies Inc. is our latest partner of choice for the 2025 Cancer Genetics & Epigenetics GRC! 🔍 Discover their cutting-edge single-cell histone and transcription factor profiling technologies: epigenome.us

🌟What is epigenetics and why is it crucial for cancer research? Meet Dr. Mathieu Lupien at University Health Network Princess Margaret Cancer Centre, newly elected Fellow of the Royal Society of Canada. His work in cancer epigenetics is transforming how we can treat breast and prostate cancer: uhnresearch.ca/news/meet-dr-m…

Big news! Recursion is a sponsor for the 2025 Cancer Genetics and Epigenetics GRC! With Recursion (recursion.com​), this GRC conference is one where advanced technologies and human ingenuity will converge to outsmart cancer’s complexity. Join us grc.org/cancer-genetic…

🚨 New meeting this fall in Brussels! 🚨 Cutting-edge science, amazing colleagues, & a RARE career development workshop for trainees-covering pharma, consulting, writing, start-ups & more 🤩 #epigenetics2025 Registration is open!! EpiCypher, Inc. Fuks_Lab xcellsconferences.com/epigenetics2025

Mathieu Lupien we are looking forward to your presentation at #EREHD25 in Mexico this November🧬 Please share with your followers to let them know our early bird & talk submission deadline has been extended, so submit & register today! 🔗bit.ly/4kNH98y

If you're into super-resolution microscopy, check out the new study from Myles Brown's lab showing dynamic, ligand-dependent changes in H3K27ac structure with implications for endocrine resistance. biorxiv.org/content/10.110…

Are you currently in the ERE related field and want to find new collaborative opportunities? Join our Chairs Kate Chiappinelli @chiappinellilab.bsky.social, Hui Shen, Ting Wang & Tao Wu at the upcoming Endogenous Retrotransposable Elements & Human Diseases Conference this November! #EREHD25 🎙️Talk

Less than a month to go until the GRC on Hormone-Dependent Cancers! Looking forward to reconnecting with the community and sharing our latest on epigenomics of ecDNAs in tumor evolution. Hope to see you then. grc.org/hormone-depend…

A jewel of a presentation on the history of chromatin. Always a pleasure to go back in time with those who helped shape it. I am grateful for the insights and stories shared by Drs. Ada and Donald Olins. youtu.be/QExPH1bVbGU